ArticleTheranostics2018

miR-200c/141 Regulates Breast Cancer Stem Cell Heterogeneity via Targeting HIPK1/β-Catenin Axis.

Bingjie Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.